R&D News | pharmaphorum

News

NIH starts trial of Moderna's mRNA Nipah virus vaccine

Researchers in the US have started a clinical trial of a vaccine against Nipah virus, a serious infection caught from animals that has a fatality rate of between 40% and 70%, developed by m

News

Vertex buys diabetes cell therapy rival ViaCyte for $320m

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880.

News

Novo Nordisk's concizumab hits mark in haemophilia, but dosi...

Novo Nordisk has reported phase 3 results with its concizumab drug for haemophilia A or B, showing efficacy in the prevention of bleeding events that will support regulatory filings startin

News

Red blood cells moving in blood vessels with depth of field.

Sanofi trumpets data with haemophilia treatment duo at ISTH

Sanofi R&D in its core haemophilia category is advancing on three fronts – engineered proteins, RNA interference drugs and gene therapies – and highlighted results in two of those at th

News

Closeup of X-ray photography of human brain

AbbVie cuts Alzheimer's alliance with Alector in half

AbbVie is pulling out of its collaboration with Alector on the development of Alzheimer's disease candidate AL003, which aims to tackle the neurodegenerative disease by restoring reduced im

News